共 193 条
[1]
Dreyling M(2005)Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network Blood 105 2677-2684
[2]
Lenz G(2002)Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study Leukemia 16 587-593
[3]
Hoster E(2012)Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur Br J Haematol 158 355-362
[4]
Van Hoof A(2013)CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d’Etude des Lymphomes de l’Adulte Blood 121 48-53
[5]
Gisselbrecht C(2015)Maintenance rituximab after autologous stem cell transplantation in patients with mantle cell lymphoma Ann Oncol 26 2323-2328
[6]
Schmits R(2017)Rituximab after autologous stem-cell transplantation in mantle-cell lymphoma N Engl J Med 377 1250-1260
[7]
Metzner B(2012)Treatment of older patients with mantle-cell lymphoma N Engl J Med 367 520-531
[8]
Truemper L(2017)Long-term results of high-dose therapy and autologous stem cell transplantation for mantle cell lymphoma: effectiveness of maintenance rituximab Biol Blood Marrow Transplant 23 1861-1869
[9]
Reiser M(2018)Total body irradiation is safe and similarly effective as chemotherapy-only conditioning in autologous stem cell transplantation for mantle cell lymphoma Biol Blood Marrow Transplant 24 282-287
[10]
Steinhauer H(2005)Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin’s lymphoma and mantle cell lymphoma J Clin Oncol 23 676-684